Journal article · 2020 · Open access
Challenges in nanomedicine clinical translation
Drug Delivery and Translational Research, 10(3), 721–725 · Published 12 March 2020 · DOI 10.1007/s13346-020-00740-5
In brief
“Challenges in nanomedicine clinical translation” is a 2020 journal article by Josbert M. Metselaar and Twan Lammers, published in Drug Delivery and Translational Research. OpenAlex counts 471 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug Delivery and Translational Research.
- Citations
- 471
- Most cited in
- 2026 (155)
- Field-weighted impact
- 8.78
- References
- 11
- Authors
- 2
Abstract
New nanomedicine formulations and novel applications of nanomedicinal drugs are reported on an almost daily basis. While academic progress and societal promise continue to shoot for the stars, industrial acceptance and clinical translation are being looked at increasingly critically. We here discuss five key challenges that need to be considered when aiming to promote the clinical translation of nanomedicines. We take the perspective of the end-stage users and consequently address the developmental path in a top-down manner. We start off by addressing central and more general issues related to practical and clinical feasibility, followed by more specific preclinical, clinical, and pharmaceutical aspects that nanomedicinal product development entails. We believe that being more aware of the end user's perspective already early on in the nanomedicine development path will help to better oversee the efforts and investments needed, and to take optimally informed decisions with regard to market opportunities, target disease indication, clinical trial design, therapeutic endpoints, preclinical models, and formulation specifications. Critical reflections on and careful route planning in nanomedicine translation will help to promote the success of nanomedicinal drugs. Graphical abstract.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Metselaar, J. M., & Lammers, T. (2020). Challenges in nanomedicine clinical translation. Drug Delivery and Translational Research, 10(3), 721–725. https://doi.org/10.1007/s13346-020-00740-5
MLA 9
Metselaar, Josbert M., and Twan Lammers. “Challenges in nanomedicine clinical translation.” Drug Delivery and Translational Research, vol. 10, no. 3, 2020, pp. 721–725. https://doi.org/10.1007/s13346-020-00740-5.
Chicago
Metselaar, Josbert M. and Twan Lammers. 2020. “Challenges in nanomedicine clinical translation.” Drug Delivery and Translational Research 10 (3): 721–725. https://doi.org/10.1007/s13346-020-00740-5.
Harvard
Metselaar, J. M. and Lammers, T. (2020) ‘Challenges in nanomedicine clinical translation’, Drug Delivery and Translational Research, 10(3), pp. 721–725. doi:10.1007/s13346-020-00740-5.
IEEE
J. M. Metselaar and T. Lammers, “Challenges in nanomedicine clinical translation,” Drug Delivery and Translational Research, vol. 10, no. 3, pp. 721–725, 2020, doi: 10.1007/s13346-020-00740-5.
BibTeX
@article{metselaar2020challenges,
title = {{Challenges in nanomedicine clinical translation}},
author = {Metselaar, Josbert M. and Lammers, Twan},
journal = {Drug Delivery and Translational Research},
year = {2020},
volume = {10},
number = {3},
pages = {721--725},
doi = {10.1007/s13346-020-00740-5},
url = {https://doi.org/10.1007/s13346-020-00740-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2020 | 8 | |
| 2021 | 37 | |
| 2022 | 41 | |
| 2023 | 67 | |
| 2024 | 62 | |
| 2025 | 100 | |
| 2026 | 155 |
Its field-weighted citation impact is 8.78: it has been cited 8.78 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- nanomedicine
- clinical translation
- drug development
- clinical trial design
- therapeutic endpoints
- preclinical models
- market opportunities
- end-user perspective
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Metselaar, J. M., & Lammers, T. (2020). Challenges in nanomedicine clinical translation. Drug Delivery and Translational Research, 10(3), 721–725. https://doi.org/10.1007/s13346-020-00740-5
How many times has this paper been cited?
471 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Drug Delivery and Translational Research: sign in and open the PDF from this page.
Who wrote this paper?
Josbert M. Metselaar, Twan Lammers.
What is the DOI of this paper?
10.1007/s13346-020-00740-5, permanently at https://doi.org/10.1007/s13346-020-00740-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.